Tuesday, March 12, 2019 2:30:14 PM
Dr. Sharpless called attention to ongoing discussions within the NCI on ways to innovatively use manufactured cellular immunotherapy products either at NCI’s Frederick National Laboratory for Cancer Research (FNLCR) or within the Intramural Research Program.
https://deainfo.nci.nih.gov/advisory/ncab/0218/minutes.pdf
Maybe while he’s at UCLA, he’ll stop by LL’s lab to see what’s cooking.
(Sorry Ex, I somehow replied to your message instead of posting a new one!)
Recent NWBO News
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
